Industries > Pharma > Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2018-2028

Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2018-2028

Retinal Disorder Drugs, Allergic, Inflammatory & Infective Drugs, Glaucoma Drugs, Dry Eye Drugs

PUBLISHED: 19 July 2018
PAGES: 223
PRODUCT CODE: PHA0324
SUBMARKET: Therapeutic Drugs

Clear
WOOCS 2.2.1
SKU: PHA0324 Categories: , Tags: , , , ,

The global ophthalmic drugs market was valued at $23bn in 2017. The market was dominated by the Retinal Disorder drug submarket which held 39.1% of the global ophthalmic drugs market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 223-page report you will receive 83 tables and 71 figures– all unavailable elsewhere.

The 223-page report provides clear detailed insight into the top ophthalmic drugs manufacturers. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Top 25 Ophthalmic Drug Manufacturers 2018-2028

Report Scope

Global ophthalmic drugs market revenue forecasts from 2018-2028

• Global ophthalmic drugs market revenue orecasts from 2018-2028, by submarket:
• Retinal Disorder Drugs
• Allergic, Inflammatory & Infective Drugs
• Glaucoma Drugs
• Dry Eye Drugs
• Other Ophthalmic Drugs

• Revenue forecasts from 2018-2028 of the leading ophthalmic drugs:
• Alphagan
• Avastin
• Azopt
• Eylea
• Lucentis
• Lumigan & Ganfort
• Other Ophthalmic Drugs
• Restasis
• Vigamix
• Xalatan/Xalacom

• Our study discusses the selected leading companies that are the major players in the ophthalmic drugs industry:
• Acucela
• Akorn
• Alimera Sciences
• Allergan
• Amakem
• Bayer
• Chengdu Kanghong
• EyeGate Pharmaceuticals
• Gene Signal
• Icon Biosciences
• MacuCLEAR
• Neurotech
• Novartis
• Omeros
• Ophthotech
• Otsuka Pharmaceutical
• Pfizer
• pSivida Corp.
• Regeneron
• Roche
• Santen
• Senju
• Shire
• ThromboGenics
• Valeant

• Our report provides an overview, revenue forecast from 2018-2028 of the ophthalmic drugs segment, revenue forecast from 2018-2028 of the leading drugs, product pipeline and SWOT Analysis, for these companies:
• Akorn
• Alcon
• Allergan
• Bausch & Lomb
• Bayer
• Novartis
• Pfizer
• Regeneron
• Roche
• Santen
• Senju
• Valeant

• Our report provides these Qualitative Analysis:
Drivers and Restraints of the Global Ophthalmic Drugs market
SWOT Analysis of selected leading companies
Porter’s Five Forces Analysis of the Global Ophthalmic Drugs Market

Visiongain’s study is intended for anyone requiring commercial analyses for the ophthalmic drugs market. You find data, trends and predictions.

Buy our report today Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2018-2028: Retinal Disorder Drugs, Allergic, Inflammatory & Infective Drugs, Glaucoma Drugs, Dry Eye Drugs.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2018-2028


Download sample pages

Complete the form below to download your free sample pages for Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2018-2028


Latest Pharma news

Visiongain Publishes Single-Use Bioreactors Market Report 2021-2031

Strong product portfolio in the market is one of the major factors accelerating the growth of the market as availability of variants in the single-use systems allows targeted users more options.

11 May 2021

READ

Visiongain Publishes ePharmacy Market Report 2021-2031

The growth in online shopping has been driven by a rapid rise in the number of smartphones, broadband connections and innovative payment products, although security remains the biggest concern. With the evolving market dynamics, merchants’ payment needs are also changing.

06 May 2021

READ

Visiongain Publishes Protein Labelling Reagents for Research Use Only (RUO) Market Report 2021-2031

Increasing investment in R&D for proteomics research, by both public and private organizations, is one of the major contributors to the growth of the protein labelling reagents market. The increasing prevalence of chronic diseases is also expected to contribute to the growth of this market.

05 May 2021

READ

Visiongain Publishes Aptamer Technologies Market Report 2021-2031

Over the last few years, the aptamers has gained widespread attention due to the technological advancements and growth in understanding of the oligonucleotide therapeutics that inhabit the human body.

29 April 2021

READ

Categories